生物粘合基托桑薄膜加载黄素为安全有效的皮肤癌局部治疗
Seila Tolentino1, Mylene M Monteiro2, Felipe Saldanha-Araújo3
1Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasília 70910-900, Brazil.
Pharmaceutics
|January 25, 2025
概括
基托桑基膜有效地提供黄素用于皮肤癌治疗,增强皮肤透率,并显示出局部治疗的前景. 这些生物粘合膜提供了一个安全和稳定的替代口服黄素的管理.
科学领域:
- 材料科学 材料科学 材料科学
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 治疗皮肤癌的口服黄素面临着药理学上的挑战.
- 局部施用提供了一种潜在的替代方案,可以提高疗效并减少全身副作用.
研究的目的:
- 开发和评估基托基生物粘合膜,用于皮肤癌治疗的局部黄素输送.
- 评估这些新型药物输送系统的安全性,有效性和药理学特性.
主要方法:
- 含有黄素的奇托桑薄膜配方,配有各种各样的辅料.
- 评估薄膜稳定性,药物释放动力学和体外皮肤透.
- 对黑色素瘤细胞的细胞毒性和皮肤刺激潜力的评估.
主要成果:
- 薄膜表现出物理稳定性和8小时的可控黄素释放.
- 与黄素溶液相比,观察到黄素的皮肤透率提高.
- 局部库尔库显示出显著的抗瘤活性,与单独的放射治疗相当.
结论:
- 基于酸盐的生物粘合膜是一种安全有效的平台,用于局部黄素的输送.
- 这些电影展示了治疗皮肤瘤的有希望的策略.
- 对结合疗法的进一步研究可能是有必要的.
相关概念视频
01:30Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K